Z. Khabadze, K. E. Sobolev, I. Todua, O. Mordanov
2020.8.1Endodontics Today
tlooto Summary
With COVID 19 (SARS-CoV-2), changes in oral mucosa are not the primary cause, but appear as a result of drug treatment and disease progression, despite the fact that the oral cavity is one of the sources of entry gates for infection.
Abstract
Aim. To study the state of oral mucosa and rationale of its changes in patients with a laboratory-confirmed diagnosis of SARS-CoV-2, moderate severity. Materials and methods. A retrospective single-center study was conducted on patients who were in the infectious diseases department from May to June 2020 with an initial diagnosis of ICD-X: J18.9: 24 ng / ml). Hemorrhagic manifestations occurred in 12 (13.3%) patients, whose history was not burdened. Pronounced xeroderma of the facial region and angular cheilitis were detected in 21 (23.3%) patients. In 80 patients (88.8%), an examination of the mucous membrane of the tongue was observed plaque from white, light yellow to brown. In 36 (40%) patients, pigmentation was detected in the area of the attached gingiva on the upper and lower jaws. Conclusions. With COVID 19 (SARS-CoV-2), changes in oral mucosa are not the primary cause, but appear as a result of drug treatment and disease progression, despite the fact that the oral cavity is one of the sources of entry gates for infection.
Citation format
KHABADZE, Z., et al. Changes in the oral mucosa and general indicators with COVID 19 (sars-cov-2): A single-center descriptive study. Endodontics Today, 2020.